The FDA announced on 2020-09-10 that Tandem Diabetes Care is recalling t:slim X2 Insulin Pumps with Dexcom G5 Mobile CGM and Basal-IQ Technology. The hazard involves unexpected battery fluctuations that can stop insulin delivery, potentially leading to hyperglycemia.
How to tell if you have it
- Brand: Tandem Diabetes Care
- Product: t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM; All Serial Numbers
- Product: t:slim X2 Insulin Pump with Basal-IQ Technology; Software Versions 6.3.01 and Earlier
- Quantity: 5,206 units
- Distribution: International distribution in Australia
The hazard
According to the FDA, insulin pumps may display unexpected fluctuations of remaining battery life. If the battery drops below 5%, insulin delivery continues for 30 minutes before the pump powers off and stops delivering insulin. If the battery reaches 1%, insulin delivery stops immediately, which could lead to hyperglycemia.
Context
GovInfoNow's records show Tandem Diabetes Care has 10 other recalls on record since 2018-04-23. Other recent recalls of similar products include Tandem t:slim App Recall: Pairing Issue With Abbott Sensors (2026-07-16), Tand: Pumps with Czech guide errors may cause insulin delivery errors (2026-01-30), and Tandem Mobi Insulin Pump Recall: False Vibration Motor Failure Risk (2025-10-06). Other recent recalls of similar products include Medtronic Paradigm Insulin Pumps Recall: Risk of Severe Hypoglycemia or Hyperglycemia (2026-02-13), Medtronic MiniMed 620G Insulin Pump Recall: Risk of Severe Hypoglycemia or Hyperglycemia (2026-02-13), and Medtronic MiniMed 740G Insulin Pump Recall: Risk of Severe Hypoglycemia or Hyperglycemia (2026-02-13).